$0.3000
-0.09-22.68%
At close: -
$0.5400
0.2480.00%
After Hours: Mar 7, 4:00 PM EDT
Comments
Loading...
Latest Mitesco Stock News | OTC:MITI | Benzinga
Get the latest news on Mitesco stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Mitesco performance
Categories: All
Monday, June 27, 2022
Friday, April 08, 2022
Thursday, January 06, 2022
Thursday, December 09, 2021
Tuesday, November 16, 2021
Wednesday, October 13, 2021
Wednesday, March 07, 2012
Friday, March 02, 2012
Wednesday, February 15, 2012
Thursday, February 02, 2012
Monday, January 30, 2012
Friday, January 27, 2012
Thursday, January 26, 2012
- Benzinga's M&A Chatter for Thursday January 26, 2012
- Ladenburg Thalmann Downgrades Micromet to Neutral
- Piper Jaffray Downgrades Micromet to Neutral
- Micromet Up 33% After Acquisition Announcement
- Micromet Resumes Trading
- Amgen to Acquire Micromet for $11 per Share Totaling $1.16B
- Micromet Halted, News Pending
Monday, January 09, 2012
Monday, December 12, 2011
Monday, November 28, 2011
Tuesday, October 25, 2011
Friday, October 14, 2011
Thursday, October 13, 2011
Wednesday, August 17, 2011
Thursday, August 04, 2011
Wednesday, July 13, 2011
Monday, July 11, 2011
Tuesday, June 14, 2011
Saturday, June 11, 2011
Friday, June 10, 2011
- Top Percentage Gainers and Losers as of 2pm 06/10/11
- Top Percentage Gainers and Losers as of 12pm 06/10/11
- Micromet Trading over 13% Higher on the Session after Positive Clinical Results
- Micromet: Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity in Patients with Relapsed Acute Lymphoblastic Leukemia
